8.97
price down icon2.92%   -0.27
pre-market  Pre-market:  8.96   -0.010   -0.11%
loading
Corbus Pharmaceuticals Holdings Inc stock is traded at $8.97, with a volume of 136.91K. It is down -2.92% in the last 24 hours and up +39.07% over the past month. Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
See More
Previous Close:
$9.24
Open:
$9.3
24h Volume:
136.91K
Relative Volume:
0.82
Market Cap:
$103.65M
Revenue:
$1.54M
Net Income/Loss:
$-38.70M
P/E Ratio:
-1.9208
EPS:
-4.67
Net Cash Flow:
$-36.86M
1W Performance:
+5.90%
1M Performance:
+39.07%
6M Performance:
-43.34%
1Y Performance:
-82.17%
1-Day Range:
Value
$8.97
$9.39
1-Week Range:
Value
$8.10
$9.4537
52-Week Range:
Value
$4.64
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Name
Corbus Pharmaceuticals Holdings Inc
Name
Phone
617-963-0103
Name
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
Employee
28
Name
Twitter
@corbuspharma
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
CRBP's Discussions on Twitter

Compare CRBP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
8.97 103.65M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.44 114.49B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
518.60 52.36B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
298.58 39.81B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
574.96 35.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
262.41 27.94B 3.81B -644.79M -669.77M -6.24

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-25 Initiated William Blair Outperform
Dec-02-24 Initiated Piper Sandler Overweight
Jul-30-24 Initiated Wedbush Outperform
Jul-22-24 Resumed H.C. Wainwright Buy
Jun-26-24 Initiated B. Riley Securities Buy
Jun-03-24 Reiterated Oppenheimer Outperform
May-13-24 Initiated RBC Capital Mkts Outperform
Mar-06-24 Upgrade Jefferies Hold → Buy
Sep-08-20 Downgrade BTIG Research Buy → Neutral
Sep-08-20 Downgrade Jefferies Buy → Hold
Sep-08-20 Downgrade RBC Capital Mkts Outperform → Sector Perform
Sep-08-20 Downgrade ROTH Capital Buy → Neutral
Jul-07-20 Initiated ROTH Capital Buy
Jun-17-20 Initiated BTIG Research Buy
Mar-26-20 Initiated Nomura Buy
Apr-05-19 Initiated Jefferies Buy
Mar-20-19 Initiated Oppenheimer Outperform
Jan-11-19 Reiterated Cantor Fitzgerald Overweight
Dec-26-18 Initiated H.C. Wainwright Buy
Dec-07-18 Initiated RBC Capital Mkts Outperform
Oct-24-18 Initiated B. Riley FBR Buy
Jan-19-18 Initiated Raymond James Outperform
Dec-14-17 Reiterated Cantor Fitzgerald Overweight
Nov-08-17 Reiterated Noble Financial Buy
Sep-29-17 Resumed Noble Financial Buy
Mar-30-17 Reiterated Cantor Fitzgerald Overweight
Nov-15-16 Reiterated JMP Securities Mkt Outperform
Nov-11-16 Reiterated Noble Financial Buy
View All

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News

pulisher
Jun 08, 2025

11,027 Shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Bought by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

(CRBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $341,000 Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Dermatomyositis Market Predicted to See Upsurge Through 2034, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Millennium Management LLC - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Acquires 11,400 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 29, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 27, 2025
pulisher
May 26, 2025

(CRBP) Proactive Strategies - news.stocktradersdaily.com

May 26, 2025
pulisher
May 23, 2025

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research

May 23, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals CEO Set to Reveal Latest Corporate Strategy at Major Jefferies Healthcare Conference - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $50.88 Average Target Price from Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

Mizuho Securities Adjusts Corbus Pharmaceuticals Price Target to $32 From $42, Maintains Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Mizuho Cuts Price Target on Corbus Pharmaceuticals Holdings to $32 From $42, Keeps Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Cannabis Stock Movers For May 20, 2025 - Benzinga

May 20, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals appoints new board chair - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals appoints new board chair By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Appoints New Chair of the Board - TipRanks

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals (CRBP) Names New Chair to Board of Direct - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Appoints Industry Leader as Chair with 3 Major Clinical Readouts Coming - Stock Titan

May 19, 2025
pulisher
May 16, 2025

(CRBP) Investment Analysis - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Is Small-Cap Corbus Pharma a Worthy Cannabis Investment? - sharewise

May 16, 2025
pulisher
May 13, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Barclays PLC - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Has $76,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 13, 2025
pulisher
May 12, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Tower Research Capital LLC TRC - Defense World

May 12, 2025
pulisher
May 10, 2025

Oppenheimer Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $56.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

B. Riley Expects Reduced Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $40.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

Wedbush Expects Weaker Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Issues Negative Forecast for CRBP Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

May 09, 2025
pulisher
May 09, 2025

Royal Bank of Canada Has Lowered Expectations for Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price - Defense World

May 09, 2025
pulisher
May 08, 2025

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold? - Zacks Investment Research

May 08, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 07, 2025
pulisher
May 07, 2025

CRBP: RBC Capital Lowers Price Target, Maintains Outperform Rati - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Lowers Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Reduced by Analyst | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Adjusted by RBC Capital | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

CRBP: HC Wainwright & Co. Lowers Price Target for Corbus Pharmaceuticals | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Adjusts Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

RBC Cuts Price Target on Corbus Pharmaceuticals Holdings to $58 From $65, Keeps Outperform, Speculative Risk - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Sees Price Target Reduction | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals: Q1 Earnings Snapshot - CTPost

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss - TipRanks

May 07, 2025
pulisher
May 06, 2025

Corbus Pharmaceuticals (CRBP) Advances Pipeline with Promising E - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corbus Pharmaceuticals Receives FDA Fast Track Designation - TipRanks

May 06, 2025

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Altmeyer Anne
Director
May 30 '25
Sale
7.25
1,392
10,096
1,391
Smethurst Dominic
Chief Medical Officer
Mar 06 '25
Sale
6.78
6,393
43,330
70,807
$22.63
price down icon 0.92%
$97.98
price up icon 7.75%
$34.05
price up icon 1.40%
$19.58
price down icon 11.32%
$105.46
price down icon 1.34%
biotechnology ONC
$262.41
price down icon 0.38%
Cap:     |  Volume (24h):